临床荟萃 ›› 2022, Vol. 37 ›› Issue (3): 204-210.doi: 10.3969/j.issn.1004-583X.2022.03.002
收稿日期:
2021-02-21
出版日期:
2022-03-20
发布日期:
2022-04-02
通讯作者:
狄亚珍
E-mail:dyz028sci@163.com
作者简介:
第一联系人:第一作者现在黄山市人民医院儿科工作
基金资助:
Hu Fangfang1, Zhong Shiling2, Di Yazhen2(), Wu Ling2
Received:
2021-02-21
Online:
2022-03-20
Published:
2022-04-02
Contact:
Di Yazhen
E-mail:dyz028sci@163.com
摘要:
目的 通过系统评价肱动脉血流介导的血管舒张(flow mediated dilation, FMD)功能与幼年特发性关节炎患儿(juvenile idiopathic arthritis, JIA)的相关性,探讨JIA患儿的血管内皮功能。方法 计算机检索Pubmed、Embase、Web of Science、The Cochrane Library、CNKI、WangFang Date、VIP数据库和CBM,搜集FMD与JIA患儿相关性的病例对照研究和横断面研究,检索时间为建库至2020年8月。由2名参与人员独立地进行文献筛选、资料提取、偏倚风险评估后,采用Reviewer Manager 5.3 及Stata 16软件进行meta分析。结果 共纳入10篇文献,6个病例对照研究,4个横断面研究,包括JIA患儿439例,健康对照组382例。Meta分析结果显示:与健康对照组比,JIA患儿的FMD值明显降低(WMD=-3.51,95%CI=-4.16~-2.85,P<0.01)。亚组分析显示:与健康对照组相比,多关节型、少关节型、全身型JIA患儿的FMD值显著降低(WMD多关节型JIA=-3.30, 95%CI=-4.51~-2.09, P<0.01;WMD少关节型JIA=-2.39, 95%CI=-3.63~-1.15, P=0.0002; WMD全身型JIA=-2.02, 95%CI=-2.57~-1.48, P<0.01)。结论 JIA患儿存在血管内皮功能障碍。
中图分类号:
胡芳芳, 钟世玲, 狄亚珍, 吴菱. 幼年特发性关节炎患儿血管内皮功能的系统评价和meta分析[J]. 临床荟萃, 2022, 37(3): 204-210.
Hu Fangfang, Zhong Shiling, Di Yazhen, Wu Ling. Vascular endothelial function of juvenile idiopathic arthritis in pediatric patients: A systematic review and meta-analysis[J]. Clinical Focus, 2022, 37(3): 204-210.
纳入研究 | 国家 | 分型 | 病程 (年) | 样本量(例) | 年龄(岁) | 性别(女,例) | BMI(kg/m2) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
病例组 | 对照组 | 病例组 | 对照组 | 病例组 | 对照组 | 病例组 | 对照组 | |||||||||||||||||||||
Hussian 2021[ | 印度 | NA | 3.67 | 81 | 78 | 12.17 | 13 | 31 | 34 | 16.73 | 18.53 | |||||||||||||||||
Ebraheem 2019[ | 埃及 | oJIA pJIA sJIA | 4 | 55 | 30 | 10.9 | 9.7 | 28 | NA | 18.6 | 18.5 | |||||||||||||||||
孙东明 2019[ | 中国 | pJIA RF(+) | 0.44 | 17 | 23 | 9.2 | 9.1 | 8 | 11 | NA | NA | |||||||||||||||||
孙东明 2019[ | 中国 | pJIA RF(-) | 0.41 | 25 | 23 | 8.9 | 9.1 | 11 | 11 | NA | NA | |||||||||||||||||
Turoňová 2018[ | 斯洛伐克 | PSA | 5.48 | 25 | 25 | 13.91 | 14.01 | NA | NA | NA | NA | |||||||||||||||||
Ali 2016[ | 埃及 | NA | 4.7 | 30 | 50 | 12.1 | 11.9 | 30 | 24 | 19.9 | 20.9 | |||||||||||||||||
Rusak 2015[ | 波兰 | NA | 3.76 | 25 | 11 | 11.33 | 12.67 | 12 | 7 | 19.05 | 18.72 | |||||||||||||||||
Amar 2015[ | 埃及 | oJIA pJIA sJIA | 4.6 | 42 | 42 | 13 | 13.1 | 24 | 22 | 19.6 | 20 | |||||||||||||||||
Satija 2014[ | 印度 | oJIA pJIA sJIA ERA | 3.097 | 31 | 31 | 10.27 | 10.27 | 18 | 18 | 15.18 | 15.91 | |||||||||||||||||
Głowińska-Olszewska 2013[ | 波兰 | NA | 3.83 | 58 | 36 | 13.0 | 13.4 | 32 | 22 | 20.6 | 19.1 | |||||||||||||||||
Vlahos 2011[ | 希腊 | oJIA pJIA sJIA | 6.58 | 30 | 33 | 12 | 12 | 21 | 21 | 19.9 | 18.9 | |||||||||||||||||
纳入研究 | TC(mg/dl) | HDL-C(mg/dl) | LDL-C(mg/dl) | TG(mg/dl) | 控制混杂 因素 | 评分 | ||||||||||||||||||||||
病例组 | 对照组 | 病例组 | 对照组 | 病例组 | 对照组 | 病例组 | 对照组 | |||||||||||||||||||||
Hussian 2021[ | 166.83 | 155.67 | 37.67 | 50 | 106.9 | 82.73 | 110.5 | 110.07 | ①⑥ | 6 | ||||||||||||||||||
Ebraheem 2019[ | 192 | 128.33 | 38.33 | 51.33 | 131.67 | 61.83 | 87 | 79.67 | ①②③⑤ | 8 | ||||||||||||||||||
孙东明 2019[ | 133.02 | 134.96 | 35.58 | 48.72 | 85.46 | 82.37 | 104.52 | 37.90 | ⑤ | 7 | ||||||||||||||||||
孙东明 2019[ | 129.54 | 134.96 | 45.63 | 48.72 | 80.82 | 82.37 | 77.95 | 37.90 | ⑤ | 7 | ||||||||||||||||||
Turoňová 2018[ | 148.88 | 147.72 | 49.88 | 52.98 | 83.14 | 81.98 | 46.04 | 42.52 | ①②③⑥⑦ | 8 | ||||||||||||||||||
Ali 2016[ | NA | NA | NA | NA | NA | NA | NA | NA | ①② | 8 | ||||||||||||||||||
Rusak 2015[ | 162 | 160.2 | 57.4 | 56 | 80.84 | 86.64 | 67 | 70.33 | ①④ | 5 | ||||||||||||||||||
Amar 2015[ | 160.7 | 157.9 | 52.7 | 52.2 | 82.6 | 83.2 | 130.6 | 131 | ① | 8 | ||||||||||||||||||
Satija 2014[ | 120.93 | 123.81 | 34.61 | 37 | 65.19 | 64.26 | 99.71 | 93.2 | ①②③⑦ | 6 | ||||||||||||||||||
Głowińska-Olszewska 2013[ | 157.39 | 153.52 | 54.14 | 55.3 | 82.37 | 80.05 | 68.2 | 64.6 | ①④ | 7 | ||||||||||||||||||
Vlahos 2011[ | 164 | 165 | 51 | 56 | 98 | 96 | 71 | 64 | ①②③⑤⑥⑦ | 6 |
表1 纳入文献的基本特征及偏倚风险评分
纳入研究 | 国家 | 分型 | 病程 (年) | 样本量(例) | 年龄(岁) | 性别(女,例) | BMI(kg/m2) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
病例组 | 对照组 | 病例组 | 对照组 | 病例组 | 对照组 | 病例组 | 对照组 | |||||||||||||||||||||
Hussian 2021[ | 印度 | NA | 3.67 | 81 | 78 | 12.17 | 13 | 31 | 34 | 16.73 | 18.53 | |||||||||||||||||
Ebraheem 2019[ | 埃及 | oJIA pJIA sJIA | 4 | 55 | 30 | 10.9 | 9.7 | 28 | NA | 18.6 | 18.5 | |||||||||||||||||
孙东明 2019[ | 中国 | pJIA RF(+) | 0.44 | 17 | 23 | 9.2 | 9.1 | 8 | 11 | NA | NA | |||||||||||||||||
孙东明 2019[ | 中国 | pJIA RF(-) | 0.41 | 25 | 23 | 8.9 | 9.1 | 11 | 11 | NA | NA | |||||||||||||||||
Turoňová 2018[ | 斯洛伐克 | PSA | 5.48 | 25 | 25 | 13.91 | 14.01 | NA | NA | NA | NA | |||||||||||||||||
Ali 2016[ | 埃及 | NA | 4.7 | 30 | 50 | 12.1 | 11.9 | 30 | 24 | 19.9 | 20.9 | |||||||||||||||||
Rusak 2015[ | 波兰 | NA | 3.76 | 25 | 11 | 11.33 | 12.67 | 12 | 7 | 19.05 | 18.72 | |||||||||||||||||
Amar 2015[ | 埃及 | oJIA pJIA sJIA | 4.6 | 42 | 42 | 13 | 13.1 | 24 | 22 | 19.6 | 20 | |||||||||||||||||
Satija 2014[ | 印度 | oJIA pJIA sJIA ERA | 3.097 | 31 | 31 | 10.27 | 10.27 | 18 | 18 | 15.18 | 15.91 | |||||||||||||||||
Głowińska-Olszewska 2013[ | 波兰 | NA | 3.83 | 58 | 36 | 13.0 | 13.4 | 32 | 22 | 20.6 | 19.1 | |||||||||||||||||
Vlahos 2011[ | 希腊 | oJIA pJIA sJIA | 6.58 | 30 | 33 | 12 | 12 | 21 | 21 | 19.9 | 18.9 | |||||||||||||||||
纳入研究 | TC(mg/dl) | HDL-C(mg/dl) | LDL-C(mg/dl) | TG(mg/dl) | 控制混杂 因素 | 评分 | ||||||||||||||||||||||
病例组 | 对照组 | 病例组 | 对照组 | 病例组 | 对照组 | 病例组 | 对照组 | |||||||||||||||||||||
Hussian 2021[ | 166.83 | 155.67 | 37.67 | 50 | 106.9 | 82.73 | 110.5 | 110.07 | ①⑥ | 6 | ||||||||||||||||||
Ebraheem 2019[ | 192 | 128.33 | 38.33 | 51.33 | 131.67 | 61.83 | 87 | 79.67 | ①②③⑤ | 8 | ||||||||||||||||||
孙东明 2019[ | 133.02 | 134.96 | 35.58 | 48.72 | 85.46 | 82.37 | 104.52 | 37.90 | ⑤ | 7 | ||||||||||||||||||
孙东明 2019[ | 129.54 | 134.96 | 45.63 | 48.72 | 80.82 | 82.37 | 77.95 | 37.90 | ⑤ | 7 | ||||||||||||||||||
Turoňová 2018[ | 148.88 | 147.72 | 49.88 | 52.98 | 83.14 | 81.98 | 46.04 | 42.52 | ①②③⑥⑦ | 8 | ||||||||||||||||||
Ali 2016[ | NA | NA | NA | NA | NA | NA | NA | NA | ①② | 8 | ||||||||||||||||||
Rusak 2015[ | 162 | 160.2 | 57.4 | 56 | 80.84 | 86.64 | 67 | 70.33 | ①④ | 5 | ||||||||||||||||||
Amar 2015[ | 160.7 | 157.9 | 52.7 | 52.2 | 82.6 | 83.2 | 130.6 | 131 | ① | 8 | ||||||||||||||||||
Satija 2014[ | 120.93 | 123.81 | 34.61 | 37 | 65.19 | 64.26 | 99.71 | 93.2 | ①②③⑦ | 6 | ||||||||||||||||||
Głowińska-Olszewska 2013[ | 157.39 | 153.52 | 54.14 | 55.3 | 82.37 | 80.05 | 68.2 | 64.6 | ①④ | 7 | ||||||||||||||||||
Vlahos 2011[ | 164 | 165 | 51 | 56 | 98 | 96 | 71 | 64 | ①②③⑤⑥⑦ | 6 |
协变量 | 回归系数 | 95%CI | t值 | P值 |
---|---|---|---|---|
年龄 | -0.503 | -0.577~0.476 | -0.22 | 0.834 |
性别 | 3.309 | -6.162~12.780 | 0.79 | 0.450 |
样本量 | -0.018 | -0.59~0.023 | -0.99 | 0.347 |
研究类型 | -0.247 | -0.217~1.676 | -0.29 | 0.778 |
病程 | 0.076 | -0.356~0.509 | 0.40 | 0.700 |
HDL-C | 0.071 | -0.037~0.179 | 1.51 | 0.169 |
LDL-C | -0.027 | -0.082~0.026 | -1.17 | 0.274 |
TG | -0.124 | -0.050~0.025 | -0.76 | 0.472 |
TC | -0.144 | -0.065~0.036 | -0.66 | 0.528 |
表2 影响效应量FMD异质性的meta回归分析
协变量 | 回归系数 | 95%CI | t值 | P值 |
---|---|---|---|---|
年龄 | -0.503 | -0.577~0.476 | -0.22 | 0.834 |
性别 | 3.309 | -6.162~12.780 | 0.79 | 0.450 |
样本量 | -0.018 | -0.59~0.023 | -0.99 | 0.347 |
研究类型 | -0.247 | -0.217~1.676 | -0.29 | 0.778 |
病程 | 0.076 | -0.356~0.509 | 0.40 | 0.700 |
HDL-C | 0.071 | -0.037~0.179 | 1.51 | 0.169 |
LDL-C | -0.027 | -0.082~0.026 | -1.17 | 0.274 |
TG | -0.124 | -0.050~0.025 | -0.76 | 0.472 |
TC | -0.144 | -0.065~0.036 | -0.66 | 0.528 |
[1] | 徐聃, 唐雪梅. 幼年特发性关节炎影像学研究进展及选择建议[J]. 中华儿科杂志, 2020, 58(12):1024-1028. |
[2] |
Theodorou K, Boon RA. Endothelial cell metabolism in atherosclerosis[J]. Front Cell Dev Biol, 2018, 6:82.
doi: 10.3389/fcell.2018.00082 pmid: 30131957 |
[3] |
Barsalou J, Bradley TJ, Silverman ED. Cardiovascular risk in pediatric-onset rheumatological diseases[J]. Arthritis Res Ther, 2013, 15(3):212.
pmid: 23731870 |
[4] | 李静. 无创血管内皮功能评价, 从科研到临床[J]. 中国心血管杂志, 2019, 24(5):411-413. |
[5] |
Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision, Edmonton, 2001[J]. J Rheumatol, 2004, 31(2):390-392.
pmid: 14760812 |
[6] |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in Meta-analyses[J]. Eur J Epidemiol, 2010, 25(9):603-605.
doi: 10.1007/s10654-010-9491-z URL |
[7] | 曾宪涛, 刘慧, 陈曦, 等. Meta分析系列之四:观察性研究的质量评价工具[J]. 中国循证心血管医学杂志, 2012, 4(4):297-299. |
[8] |
Luo D, Wan X, Liu J, et al. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range[J]. Stat Methods Med Res, 2018, 27(6):1785-805.
doi: 10.1177/0962280216669183 URL |
[9] |
Hussain KS, Gulati R, Satheesh S, et al. Early-onset subclinical cardiovascular damage assessed by non-invasive methods in children with juvenile idiopathic arthritis: Analytical cross-sectional study[J]. Rheumatol Int, 2021, 41(2):423-429.
doi: 10.1007/s00296-020-04689-z URL |
[10] |
Fathy EM, Raouf AE, Mohsen MA, et al. Vascular cell adhesion molecule-1 (VCAM-1), flow mediated dilatation (FMD) and carotid intima media thickness (IMT) in children with juvenile idiopathic arthritis: Relation to disease activity, functional status and fatigue[J]. Egyptian Rheumatologist, 2019, 41(2):145-150.
doi: 10.1016/j.ejr.2018.05.007 URL |
[11] | 孙东明, 高峻, 丁艳, 等. 多关节型幼年特发性关节炎活动期血管内皮功能研究[J]. 中国实用儿科杂志, 2019, 34(10):845-848. |
[12] | Turoňová L, Kubejová K, Vorˇcáková K, et al. Endothelial Dysfunction in Children with Juvenile Psoriatic Arthritis[J]. Acta medica (Hradec Kralove), 2018, 61(3):79-85. |
[13] |
Ali A. Subclinical heart failure in juvenile idiopathic arthritis: A consequence of chronic inflammation and subclinical atherosclerosis[J]. Egyptian Rheumatology and Rehabilitation, 2016, 43(2):78-83.
doi: 10.4103/1110-161X.181881 URL |
[14] |
Rusak M, Radzikowska U, Glowinska-Olszewska B, et al. Endothelial progenitor cell levels in juvenile idiopathic arthritis patients: Effects of anti-inflammatory therapies[J]. Pediatr Rheumatol Online J, 2015, 13:6.
doi: 10.1186/s12969-015-0001-4 URL |
[15] | Amar HA, Elhewala A. Subclinical atherosclerosis in Egyptian children with JIA: Assessment of the risk factors[J]. Int J Adv Res, 2015, 3(11) :1138-1150. |
[16] |
Satija M, Yadav TP, Sachdev N, et al. Endothelial function, arterial wall mechanics and intima media thickness in juvenile idiopathic arthritis[J]. Clin Exp Rheumatol, 2014, 32(3):432-439.
pmid: 24564946 |
[17] | Głowińska-Olszewska B, Bossowski A, Dobreńko E, et al. Subclinical Cardiovascular System Changes in Obese Patients with Juvenile Idiopathic Arthritis[J]. Mediators Inflamm, 2013, 2013:436702. |
[18] |
Vlahos AP, Theocharis P, Bechlioulis A, et al. Changes in vascular function and structure in juvenile idiopathic arthritis[J]. Arthritis Care Res (Hoboken), 2011, 63(12):1736-1744.
doi: 10.1002/acr.20613 URL |
[19] | 张天嵩, 刘江波, 钟文昭. Stata在探索异质性来源—Meta回归分析中的应用[J]. 循证医学, 2009, 9(1):48-50. |
[20] |
Mizuta M, Shimizu M, Inoue N, et al. Serum ferritin levels as a useful diagnostic marker for the distinction of systemic juvenile idiopathic arthritis and Kawasaki disease[J]. Mod Rheumatol, 2016, 26(6):929-932.
doi: 10.3109/14397595.2016.1159120 pmid: 27433933 |
[21] |
Bohr AH, Fuhlbrigge RC, Pedersen FK, et al. Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures[J]. Pediatr Rheumatol Online J, 2016, 14(1):3.
doi: 10.1186/s12969-015-0061-5 URL |
[22] |
Breda L, Di Marzio D, Giannini C, et al. Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis[J]. Clin Res Cardiol, 2013, 102(1):63-71.
doi: 10.1007/s00392-012-0496-3 pmid: 22885951 |
[23] | Pietrewicz E, Urban M. Early atherosclerosis changes in children with juvenile idiopathic arthritis[J]. Pol Merkur Lekarski, 2007, 22(129):211-214. |
[24] |
Argyropoulou MI, Kiortsis DN, Daskas N, et al. Distensibility and pulse wave velocity of the thoracic aorta in patients with juvenile idiopathic arthritis: An MRI study[J]. Clin Exp Rheumatol, 2003, 21(6):794-797.
pmid: 14740462 |
[25] |
Zhang C, Hein TW, Wang W, et al. Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles[J]. J Mol Cell Cardiol, 2006, 40(2):247-257.
doi: 10.1016/j.yjmcc.2005.11.010 URL |
[26] |
Ait-Oufella H, Taleb S, Mallat Z, et al. Recent advances on the role of cytokines in atherosclerosis[J]. Arterioscler Thromb Vasc Biol, 2011, 31(5):969-979.
doi: 10.1161/ATVBAHA.110.207415 pmid: 21508343 |
[27] |
Kou F, Zhu C, Wan H, et al. Endothelial progenitor cells as the target for cardiovascular disease prediction, personalized prevention, and treatments: progressing beyond the state-of-the-art[J]. EPMA J, 2020, 11(4):629-643.
doi: 10.1007/s13167-020-00223-0 URL |
[28] |
Kim JH, Kim JY, Park M, et al. NF-κB-dependent miR-31/155 biogenesis is essential for TNF-α-induced impairment of endothelial progenitor cell function[J]. Exp Mol Med, 2020, 52(8):1298-1309.
doi: 10.1038/s12276-020-0478-x URL |
[29] |
Martini G, Biscaro F, Boscaro E, et al. Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy[J]. BMC Musculoskelet Disord, 2015, 16:103.
doi: 10.1186/s12891-015-0555-9 URL |
[30] |
Incalza MA, D'Oria R, Natalicchio A, et al. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases[J]. Vascul Pharmacol, 2018, 100:1-19.
doi: 10.1016/j.vph.2017.05.005 URL |
[31] |
Blum A, Adawi M. Rheumatoid arthritis (RA) and cardiovascular disease[J]. Autoimmun Rev, 2019, 18(7):679-690.
doi: 10.1016/j.autrev.2019.05.005 URL |
[32] | Ruan Y, Jiang S, Musayeva A, et al. Oxidative stress and vascular dysfunction in the retina: Therapeutic strategies[J]. Antioxidants (Basel), 2020, 9(8):761. |
[33] |
Wu NN, Tian H, Chen P, et al. Physical exercise and selective autophagy: Benefit and risk on cardiovascular health[J]. Cells, 2019, 8(11):1436.
doi: 10.3390/cells8111436 URL |
[34] |
Fazaa A, Sellami M, Ouenniche K, et al. Physical activity assessment in children and adolescents with juvenile idiopathic arthritis compared with controls[J]. Arch Pediatr, 2021, 28(1):47-52.
doi: 10.1016/j.arcped.2020.10.008 pmid: 33250332 |
[35] | 马孝湘, 王林, 杨雁华, 等. 健康管理对正常高值血压患者血压及血管内皮依赖性舒张功能影响的研究[J]. 四川医学, 2020, 41(5):468-471. |
[1] | 龚财芳, 赵俊宇, 游川. 接纳与承诺疗法对癌症患者心理健康和生活质量影响的meta分析[J]. 临床荟萃, 2024, 39(2): 101-107. |
[2] | 肖煌怡, 袁建坤, 严梓予, 曾雯姝, 鲁兰莫, 王峻. 认知干预对遗忘型轻度认知障碍老年患者干预效果的meta分析[J]. 临床荟萃, 2024, 39(1): 12-19. |
[3] | 吕畅, 周利明. TNF-α-308基因多态性与胃癌易感相关性的meta分析[J]. 临床荟萃, 2023, 38(9): 779-787. |
[4] | 李海, 刘文虎, 彭绍鹏, 王飞. 控制性阶梯式减压术对比快速标准大骨瓣减压术治疗重度颅脑损伤疗效的meta分析[J]. 临床荟萃, 2023, 38(9): 788-795. |
[5] | 侯有玲, 李奕, 关红玉, 罗红霞. 目标导向液体治疗在脑肿瘤切除术中应用效果的meta分析[J]. 临床荟萃, 2023, 38(8): 686-693. |
[6] | 金家辉, 杨阳, 秦铜, 何雨欣, 苏美华. 补充益生菌对2型糖尿病患者糖代谢改善的meta分析[J]. 临床荟萃, 2023, 38(7): 581-587. |
[7] | 肖王静, 李欣梦, 卢松玲, 孙雪华. 重复经颅磁刺激治疗中枢神经源性吞咽障碍疗效及安全性的meta分析[J]. 临床荟萃, 2023, 38(7): 588-599. |
[8] | 尤奕, 高淑清, 徐浩. 肠内营养对食管癌患者术后临床结局影响的系统综述[J]. 临床荟萃, 2023, 38(6): 485-492. |
[9] | 倪艺芸, 刘彬, 梁琪, 李晓凤. 白细胞介素6和C反应蛋白预测新型冠状病毒肺炎严重程度的meta分析[J]. 临床荟萃, 2023, 38(6): 493-499. |
[10] | 沃拉孜汗·玛德尼亚提, 迪力夏提·图尔迪麦麦提, 李梦晨, 拜合提尼沙·吐尔地. 宏基因组二代测序技术在肺结核诊断中应用价值的meta分析[J]. 临床荟萃, 2023, 38(5): 389-398. |
[11] | 赵哲, 穆培娟, 张冬. 恩度联合顺铂胸腔灌注治疗肺癌合并恶性胸腔积液疗效的meta分析[J]. 临床荟萃, 2023, 38(5): 399-404. |
[12] | 马明福, 魏志国, 何铁英. 急性胰腺炎并发胰腺假性囊肿危险因素的meta分析[J]. 临床荟萃, 2023, 38(4): 293-301. |
[13] | 曹宇萌, 张海燕, 刘立新. 非酒精性脂肪性肝病的病理改变与血清铁蛋白和血清铁含量变化关系的meta分析[J]. 临床荟萃, 2023, 38(3): 197-207. |
[14] | 马宏莉, 陆皓, 王丹, 焦海星, 李一珂, 李思雨, 吕静. 脑卒中患者残疾危险因素的meta分析[J]. 临床荟萃, 2023, 38(2): 111-116. |
[15] | 陶嘉楠, 李文茜, 马秀雯, 安琪, 王学红. HER-2在肝细胞癌中表达及临床意义的meta分析[J]. 临床荟萃, 2023, 38(12): 1067-1072. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||